Blue Trust’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Other funds holding BIO
Blue Trust's BIO Position: Q3 2026 in Review
Blue Trust reduced its Bio-Rad Laboratories Class A (BIO) stake by 4.8% in Q3 2026, selling an estimated $26.2K and leaving 1,496 shares worth $565K. The position accounts for 0.01% of the portfolio, ranked #442.
Blue Trust first reported a position in BIO in Q2 2022 and has held it in 18 quarters since. 327 funds tracked by Wall St. Rank hold BIO as of Q3 2026.
- Blue Trust held 1,496 shares of Bio-Rad Laboratories Class A worth $565K as of Q3 2026.
- Blue Trust sold 75 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $26.2K.
- Bio-Rad Laboratories Class A made up 0.01% of Blue Trust's portfolio in Q3 2026, its #442 holding.
- Blue Trust first reported a position in Bio-Rad Laboratories Class A in Q2 2022 and has held it in 18 quarters since.
- 327 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.
Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.